# Clinical Trial Nuedexta in Subjects With ALS

> **NCT01806857** · PHASE2 · COMPLETED · sponsor: **Center for Neurologic Study, La Jolla, California,** · enrollment: 90 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

- **DRUG:** Nuedexta
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT01806857
- **Lead sponsor:** Center for Neurologic Study, La Jolla, California,
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2017-03-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01806857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01806857, "Clinical Trial Nuedexta in Subjects With ALS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01806857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*